FAQs アーカイブ - Biozipcode, Inc.

Q: What is the long-term strategy for growth and expansion in domestic and international markets?

The expansion into international markets is being considered based on the regulations and market demands of each country. Diabetes is a global health issue, and international demand is anticipated. Patent licensing agreements and other preparations are being made in each country before the completion of international patent transfers. Note: The term 'domestic' refers to within Japan.

Q: Are clinical trials and research for diabetes cure methods and products ongoing, and what have been the results so far?

The new drug targets all patients, including those with Type 1 and Type 2 diabetes, and is effective for diabetes complications. It is currently in the planning stage of clinical trials. Animal experiments are being conducted on mice and also on larger animals.

Q: What are the main research and development areas, and how do they align with the company's long-term goals?

The main research and development areas are: (1) Developing drugs that completely cure diabetes and its complications, focusing on specific cells that are the root cause of diabetes, and working on new diagnostic and treatment drugs. (2) Advancing new ventures in the application of Biozipcode technology (cell targeting technology).

Q: Could you tell us about the current capital and sources of funding?

Biozipcode, Inc. was established in January of Reiwa year 4th (2022) with a capital of 70 million yen. Funding has been provided by Representative Director Fumihisa Kojima and Studio Makyu Co., Ltd, along with their collaborating companies. The development costs for new drugs usually range from several tens of million to hundred millions of USD, and funding is planned through investors, VCs, government and private grants, and partnerships for joint research.

Q: How is Biozipcode, Inc. addressing untreated diseases like diabetes?

Biozipcode, Inc. is dedicated to tackling untreated diseases such as diabetes and providing fundamental treatment methods. To achieve this goal, the company conducts research using cutting-edge scientific technology to delve into the essence of diseases. It focuses on achieving a complete cure for diabetes, emphasizing scientific discovery and societal understanding and support.

Q: What process will be followed for the survey to establish a medical school in Palau?

The survey for establishing a medical school in Palau will be conducted through a comprehensive and phased approach. Initially, an assessment of local healthcare needs and educational resources will be performed. Following this, detailed plans for possible campus locations, educational facilities, and academic program designs will be formulated. This process will involve consultations with government agencies, education experts, the local community, and international partners, aiming to establish a sustainable and effective medical education institution tailored to the region's needs.

Q: How will the latest medical advancements in diabetes treatment be applied in Palau?

The latest medical advancements in diabetes treatment will be applied in Palau through educational programs, clinical trials, and customized treatment plans.This includes the introduction of new drug therapies, lifestyle modification strategies, and technological tools for diabetes management. Training local medical professionals and enhancing patients' self-management skills are also crucial. This approach will enable the latest insights in diabetes prevention and management to be utilized locally.

Q: How will the clinic at Sheraton Palau collaborate with the local community?

The future clinic at Sheraton Palau will collaborate with the local community by understanding their needs and providing community-based health programs. This includes regular meetings with local leaders (High Chiefs) and residents of Koror State and the main island, conducting health education sessions, and offering medical services sensitive to local culture and traditions. This approach will establish the clinic as a part of the community and enable it to deliver more effective healthcare.

Q: What are the main challenges in establishing a medical school in the Republic of Palau?

The main challenges in establishing a medical school in the Republic of Palau include securing appropriate educational resources, recruiting quality faculty, and developing a curriculum that fits local culture and needs. Ensuring facilities and equipment that meet international medical education standards, as well as providing student support and career development programs, are also significant challenges. Addressing these challenges requires close cooperation with the government, educational institutions, and the medical community. Currently, there is no university in the Republic of Palau.

Q: How will the treatment methods aimed at the complete cure of diabetes be implemented locally?

Treatment methods aimed at the complete cure of diabetes are first developed based on the latest medical research and clinical trials. These methods are integrated into local medical protocols in close cooperation with the Palau community. Local medical professionals are educated and trained to implement these methods. Patient follow-up and assessment of treatment outcomes also help improve treatment methods and maximize their effectiveness.

FAQs

KIYAN Group and Collaborating Research Institutions

KIYAN PHARMA Co., Ltd.

KIYAN MEDICAL Co., Ltd.

Biozipcode, Inc.

Shiga University of Medical Science, Dep. of Regenerative Medicine

Biozipcode, Inc.

Learn More About Us

Contact Us

Languages